Clinical trial
Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
NCT00152633 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- September 30, 2005
- Completion date
- January 31, 2006
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.